“Benefits of Sequential Treatment of High Risk Osteoporosis With Teripartide and Denosumab: Our Experience”. 2024. Actualizaciones En Osteología 12 (1): 27-34. https://ojs.osteologia.org.ar/aaomm/index.php/osteologia/article/view/288.